• Home
  • Search Results

Search Results

395 studies match your search
Open

Alpha-1 Antitrypsin TDN

Do you have Alpha-1 Antitrypsin Deficiency? Do you want to participate in research? You may be able to participate in a research project to be contacted for future research studies. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
  • Rare Diseases
Open

The Life Experiences and Emotion Development (LEED) Study

Is your child age 5,6 or 7? If so, you may be eligible for the LEED study on emotional development and mental health in children. You and your child can earn up to $695 in a combination of cash, gift cards, and prizes! No travel required!

Age & Gender
  • 5 years ~ 7 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Developmental
  • Mental and Emotional Health
  • and 4 more
Visit Location
Open

Adults with Blood Cancer

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AZD9829 to patients with Leukemia.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Immunotherapy study for patients with stage II-III breast cancer

Do you have Stage II or III Breast cancer? If you have enough tissue from your breast cancer diagnosis to send for Mammaprint genomic testing, you may be able to take part in this research study. In this study, we want to learn more about adding an immunotherapy drug, durvalumab, to your chemotherapy treatment. The Mammaprint testing is conducted at no cost to you and the cost of durvalumab is covered.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
Open

Randomized Phase III Trial of mFOLFIRINOX vs. FOLFOX With Nivolumab

Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Stomach and Esophageal)
Open

Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin s Lymphoma

Do you have a type of cancer known as Relapsed Hodgkin's Lymphoma?Has your cancer come back, or not get better with the last treatment you received ? If so, you may be able to participate in a gene therapy study to see if we can use your body's own immune cells as a treatment for your HL. (Example: Do you know your blood pressure? Do you sit too much at work? If you have a desk job and higher than normal blood pressure (but are not taking blood pressure medication), you may be able to participate in a research study to find out if sitting less during the workday can lower

Age & Gender
  • 3 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

AYA Connect

Are you a young adult cancer survivor who would like to lose weight? Interested in using technology to support a healthy diet, get more physically active, and improve your mental health? Researchers at the University of North Carolina at Chapel Hill are looking for volunteers to sign up for a 6-month research program that will involve using a Fitbit activity tracker, digital smart scale, and mobile app. For more information and to see if you qualify, visit our study website at www.uncweightresearch.org

Age & Gender
  • 18 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Eating, Nutrition, and Metabolism
  • Obesity
  • Wellness and Lifestyle
  • Movement
Visit Location
100% Remote (online, phone, text)
Open

ACL Research Study

Have you had an ACL reconstruction? UNC Orthopaedics is looking for people between 13-25 years old to participate in a one-session research study to measure muscle strength and physical performance using state-of-the-art wearable sensors. Compensation up to $320.

Age & Gender
  • 13 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Injury/Injury Prevention
Open

Advanced Melanoma Tumor Study

Do you have an advanced melanoma tumor and have received prior systemic therapy? Has your cancer progressed on the other treatments? If so, the you may be able to take part in a study to help us learn the safety and dosage of the drug AB248 on solid tumors.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Open

Randomized Phase 2 Study of Cabozantinib, Ipilimumab, and Nivolumab in Patients With Soft Tissue Sarcoma

Do you have advanced soft tumor sarcoma? Is your tumor surgically unresectable? If so, then you may be able to take part in a study to help us learn if a combination of 3 study drugs will affect the progression of Soft Tissue Sarcoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Sarcoma (bone and soft tissue))
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research